Immunosuppressive treatment of multiple sclerosis and risk (of reactivation) of viral hepatitides

Abstract

The article presents a current perspective on the risk of reactivation of viral hepatitides in association with the administration of drugs with an immunosuppressive effect to treat multiple sclerosis. The aim of the article is to provide a practical approach for testing viral hepatitides prior to initiation of immunosuppressive treatment, taking into account recommendations resulting from the summaries of individual products.

Keywords

• viral hepatitis
• multiple sclerosis
• immunosuppressive treatment